Other Events ·
On August 7, 2026, BioRestorative Therapies, Inc. suspended all orders and shipments of its ExoCR and BioX…
BRTXBioRestorative Therapies, Inc.
On August 7, 2026, BioRestorative Therapies, Inc. suspended all orders and shipments of its ExoCR and BioX biocosmeceutical product lines pending a business review and regulatory assessment. The company has not decided to discontinue these products but is reviewing documentation, sourcing, and regulatory status. This operational halt introduces uncertainty regarding near-term revenue from these lines and potential associated costs. BioRestorative Therapies, Inc. operates in the biotechnology sector, developing regenerative medicine therapies and biocosmeceutical skincare products.